C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids

More topics under "C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids" (173,078)
C07H 1 - Processes for the preparation of sugar derivatives (12,374)
C07H 11 - Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof (1,722)
C07H 13 - Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids (4,753)
C07H 15 - Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals (17,975)
C07H 17 - Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals (11,681)
C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008)
C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
C07H 23 - Compounds containing boron, silicon, or a metal, e.g. chelates, vitamin b12 (1,716)
C07H 3 - Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms (5,762)
C07H 5 - Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium (3,671)
C07H 7 - Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond (2,294)
C07H 9 - Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical (1,178)
C07H 99 - Subject matter not provided for in other groups of this subclass (52)

Patents for C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids (1,168)
02/1993
02/10/1993	CN1068738A Modulation and diagnosis of cytokine dysfunctions
02/04/1993	WO1993001717A1 Modulation and diagnosis of cytokine dysfunctions
02/04/1993	CA2113573A1 Modulation and diagnosis of cytokine dysfunctions
02/03/1993	CN1068574A Atp analogues
01/1993
01/21/1993	WO1993001201A1 Mono and bis alkylamino-anthracyclines
01/20/1993	CN1068035A Abrogation of uiral resistance to nucleoside analogues by double-stranded rnas
01/19/1993	CA1312862C Erythromycin derivative and process for preparing the same
01/07/1993	EP0521458A1 Mono and bis alkylamino-anthracyclines
12/1992
12/09/1992	CN1019387B Process for prepn. of propanol derivatives
11/1992
11/24/1992	CA1310642C 2-amino-5-hydroxy-4-pyrimidones
11/24/1992	CA1310637C Epipodophyllotoxin glucoside 4'-phosphate derivatives
11/17/1992	WO1992020695A1 Method for the preparation and purification of a mixture of glycosphingolipids free from contamination by non-conventional viruses
11/17/1992	CA2087158A1 Method for the preparation and purification of a mixture of glycosphingolipids free from contamination by non-conventional viruses
10/1992
10/29/1992	WO1992018004A1 ABROGATION OF VIRAL RESISTANCE TO NUCLEOSIDE ANALOGUES BY DOUBLE-STRANDED RNAs
10/29/1992	WO1992015601A3 Heteroanthracycline antitumor analogs
10/29/1992	CA2102221A1 Abrogation of viral resistance to nucleoside analogues by double-stranded rnas
10/20/1992	WO1992018543A1 Procedure for the purification of hyaluronic acid and fraction of pure hyaluronic acid for ophthalmic use
10/14/1992	EP0508687A1 ATP analogues
10/07/1992	WO1992017488A1 Atp analogues
10/07/1992	CN1065069A Process for preparing erythromycin derivatives
10/07/1992	CA2107667A1 Atp analogues
10/06/1992	US5153312 Respiratory system disorders
09/1992
09/09/1992	EP0502661A2 Heteroanthracycline anti-tumor analogues
08/1992
08/29/1992	WO1992015601A2 Heteroanthracycline antitumor analogs
08/29/1992	CA2104768A1 Heteroanthracycline antitumor analogs
08/26/1992	EP0500143A2 Pharmaceutical composition comprising an aminoglycoside phosphate
08/12/1992	EP0498471A2 Liposomes comprising a guanidino aminoglycoside
08/04/1992	CA1305931C Yeast strains producing cellulolytic enzymes and methods and means for constructing them
07/1992
07/15/1992	CN1017451B Method for the preparation of vaccine
06/1992
06/25/1992	WO1992010212A1 Anthracycline-conjugates
06/16/1992	US5122368 Anthracycline conjugates having a novel linker and methods for their production
06/16/1992	CA1303611C Chromogenic acridinone enzyme substrates
06/11/1992	WO1992002534A3 Compounds and methods for inhibiting gene expression
05/1992
05/27/1992	EP0487411A1 Erythromycin derivatives, their preparation, intermediates obtained and their application as medicaments
05/27/1992	CN1016785B Azithromycin dihydrate
05/20/1992	EP0486477A2 1-( -D-Arabinofuranosyl)-5-propynyluracil as a VZV-antiviral compound
05/20/1992	CN1061225A Epiodophylltoxin glucoside 4'-phosphate
04/1992
04/15/1992	CN1060294A Improved oligosaccharide conjugate vaccines
04/02/1992	WO1992005287A1 Enzymatic synthesis of oligonucleotides
04/01/1992	EP0477508A1 Improved oligosaccharide conjugate vaccines
03/1992
03/22/1992	CA2069096A1 Enzymatic synthesis of oligonucleotides
03/19/1992	WO1992004364A1 A method of linking nucleosides with a siloxane bridge
03/19/1992	CA2091559A1 Method of linking nucleosides with a siloxane bridge
03/18/1992	EP0216786B1 Purification, production and use of tumor necrosis factors
03/11/1992	EP0205506B1 A method of transforming fungi with a vector
03/05/1992	WO1992003456A1 Oligonucleotides for modulating the effects of cytomegalovirus infections
02/1992
02/25/1992	CA1296273C Recombinant methods for production of serine protease inhibitors and methods for isolation of same
02/20/1992	WO1992002255A1 New linker for bioactive agents
02/12/1992	CN1058598A New linker for bioactive agents
02/04/1992	WO1992002534A2 Compounds and methods for inhibiting gene expression
02/04/1992	CA2088673A1 Compounds and methods for inhibiting gene expression
02/02/1992	CA2088499A1 Dynemicin analogs: syntheses, methods of preparation and use
01/1992
01/08/1992	EP0464137A1 Inhibition of hiv using synergistic combinations of nucleoside derivatives
01/07/1992	US5079235 5-Substituted Pyrimidine Nucleosides
01/07/1992	US5079233 N-acyl derivatives of the LL-E33288 antitumor antibiotics, composition and methods for using the same
01/02/1992	EP0462980A1 Platinum pharmaceutical agents
12/1991
12/04/1991	EP0459536A1 Chromogenic acridinone enzyme substrates
11/1991
11/12/1991	CA1292002C Propanol derivatives
10/1991
10/15/1991	CA1290751C Process for preparing netilmicin
09/1991
09/10/1991	US5047407 Prevention Or Treatment Of Human Immunodeficiency Virus
08/1991
08/20/1991	US5041424 Epipodophyllotoxin glucoside 4'-phosphate derivatives
08/07/1991	EP0210203B1 Propanol derivatives
07/1991
07/24/1991	CN1053265A Human c3b/c4b receptor (cr1)
06/1991
06/12/1991	EP0242385B1 Process for preparing netilmicin
05/1991
05/14/1991	US5015573 DNA vectors and their use in recombinant DNA technology
03/1991
03/20/1991	EP0417560A1 Antiviral compounds
03/12/1991	US4999291 Production of human pluripotent granulocyte colony-stimulating factor
02/1991
02/06/1991	EP0411031A1 THE HUMAN C3b/C4b RECEPTOR (CR1)
01/1991
01/24/1991	WO1990009163A3 Method and compounds for aica riboside delivery and for lowering blood glucose
01/09/1991	CN1048390A N-acyl derivatives of ll-e 33288 antitumor antibiotics
12/1990
12/12/1990	CN1047676A Antiviral, highly water soluble, stable, crystalline salts of 2',3;-dideoxyinosine monohydrate, 2',3'-dideoxy-2',3'-didehydrothymidine monohydrate and 2',3'-dideoxy-2'-fluoroinosine hemihydrate
11/1990
11/22/1990	EP0398230A2 Antiviral, highly water soluble, stable, crystalline salts of 2',3'-dideoxyinoside monohydrate, 2',3'-dideoxy-2',3'-didehydrothymidine monohydrate and 2',3'-dideoxy-2'-fluoroinosine hemihydrate
11/13/1990	CA1276400C Process for producing (amido)n-substituted bleomycins
10/1990
10/24/1990	CN1046333A Antitumor and antibacterial substituted disulfide derivatives prepared from compounds possessing methyle-trithio group, and targeted forms thereof
10/17/1990	EP0392384A2 Targeted forms of methyltrithio antitumor agents
10/17/1990	EP0392376A2 N-acyl derivatives of the LL-E33288 antitumor antibiotics
10/03/1990	CN1045791A Inhibition of hiv using synergistic combinations of nucleosides derivatives
09/1990
09/20/1990	WO1990010637A1 Method for purifying nucleic acids
09/18/1990	WO1990011081A1 Inhibition of hiv using synergistic combinations of nucleoside derivatives
09/18/1990	CA2050473A1 Inhibition of hiv using synergistic combinations of nucleoside derivatives
08/1990
08/23/1990	WO1990009163A2 Method and compounds for aica riboside delivery and for lowering blood glucose
08/22/1990	CN1044817A 2-substituted-5-substituted-1, 3-oxathiolanes with antiviral properties
08/16/1990	EP0382526A2 Substituted -1,3-oxathiolanes with antiviral properties
08/07/1990	US4946954 Platinum pharmaceutical agents
07/1990
07/24/1990	CA2008325A1 Method and compounds for aica riboside delivery and for lowering blood glucose
07/18/1990	WO1990008157A1 Platinum pharmaceutical agents
07/18/1990	CN1043941A C63-amide derivatives of 34-de(acetyl-glucosaminyl)-34-deoxy-teicoplanins
07/18/1990	CA2045120A1 Platinum pharmaceutical agents
07/04/1990	EP0376041A2 C63-Amide derivatives of 34-de(acetylglucosaminyl)-34-deoxy-teicoplanins
06/1990
06/27/1990	CA2006379A1 C63-amide derivatives of 34-de(acetylglucosaminyl)-34-deoxy- teicoplanins
06/20/1990	EP0374096A1 Combination therapy involving 2',3'-dideoxypurine nucleoside and an inhibitor of purine nucleoside phosphorylase, and its compositions
06/14/1990	CA2005205A1 2',3'-dideoxypurine nucleoside/purine nucleoside phosphorylase inhibitor combination therapy and composition
06/12/1990	US4933510 Propanol derivatives
05/1990
05/16/1990	EP0368367A1 Purification, production and use of tumor necrosis factors
05/08/1990	US4923978 Process for purifying nucleic acids
02/1990
02/27/1990	US4904768 Epipodophyllotoxin glucoside 4'-phosphate derivatives
01/1990
01/30/1990	CA1265132A1 Process for the organic synthesis of oligosaccharides and derivatives thereof
01/23/1990	CA1264738A1 Treatment of tumors in mammals
01/16/1990	US4894449 Gastrointestinal disorders
01/16/1990	US4894338 Dna, gene expression, cloning

1 2 3 4 5 6 7 8 9 10 11 12